Disease Modeling and Drug Discovery
疾病建模及新藥研發(fā)
2014年8月25-29日| 蘇州.獨(dú)墅湖會議酒店
大會官網(wǎng):
科學(xué)組委會成員:
Yanhong Shi, Beckman Research Institute of City of Hope, USA
Michael Yaffe, California Institute for Regenerative Medicine, USA
Duanqin Pei, Guangzhou Institute of Biomedicine and Health, China
Toru Takumi, RIKEN Brain Science Institute, Japan
科學(xué)顧問:
Shinya Yamanaka, Kyoto University, Japan
Gang Pei, Shanghai Institutes of Academy of Sciences, China
會議主題:
Cardiac disease modeling and drug discovery
Modeling psychiatric disorders using animal models
Modeling neurodevelopmental diseases using iPSCs
Dissecting neurodegenerative diseases using stem cells
Drug discovery using disease models
Cellular reprogramming
Clinical applications of disease models
Translating discovery to the clinics
主題演講嘉賓:
Lorenz Studer, Sloan-Kettering Institute for Cancer Research, USA
Roberto Iacone, Hoffman-La Roche Ltd, Switzerland, SWITZERLAND
Abstract title:Disease modeling and phenotypic drug screening for diabetic cardiomyopathy using human inducible pluripotent stem cells
特邀演講嘉賓:
Anne G. Bang, Sanford-Burnham Medical Research Institute, USA
Abstract title:Human Induced Pluripotent Stem Cells and Patient Specific Cell-Based Disease Models for Drug Discovery
Thomas Bourgeron, Institut Pasteur, FRANCE
Abstract title:Genes, Synapses and Autisms
Arlene Chiu, Beckman Research Institute of City of Hope, USA
Abstract title: The Rocky Road from Discovery to Treatment
Ing-Ming Chiu, National Health Research Institutes, Taiwan, TAIWAN
Abstract title: Neural Stem Cells and Induced Neurons in Peripheral Nerve Injury Repair
Alan Colman, Harvard University / Institute of Medical Biology, Singapore
Abstract title: The X Factor: Dynamics of X Chromosome Expression during and after Reprogramming of Human Somatic Cells
Dieter Egli, The New York Stem Cell Foundation Research Institute, USA
Abstract title:Reprogramming in Human Ooyctes
Yadong Huang, University of California San Francisco, Gladstone Institute, USA
Abstract title: Modeling Neurodegenerative Diseases and Drug Screening Using Human iPSCs
Haruhisa Inoue, Kyoto University, JAPAN
Abstract title:The Use of iPSCs toward the Treatment of Neurodegenerative Diseases
Juan Carlos Izpisua Belmonte, the Salk Institute, USA
Abstract title:Disease Models for Tissue and Organ Regeneration
Dong-Wook Kim, Yonsei University College of Medicine, Korea
Abstract title: Modeling and Drug Discovery of X-linked Adrenoleukodystrophy using iPS Cells
Eric Klann, New York University, USA
Abstract title: Translating Translational Control in Brain Disorders
Guo-Li Ming, Johns Hopkins University, USA
Abstract title: Modeling Complex Psychiatric Disorders Using iPSCs
Stephen Minger, GE Healthcare, UK
Abstract title: Innovating Preclinical Drug Discovery and Human Cell Therapy
Lisa Monteggia, UT Southwestern Medical Center at Dallas, USA
Abstract title: Mechanism of Rapid Antidepressant Action
Duanqing Pei, Chinese Academy of Sciences, CHINA
Abstract title:TBA
Bruno Reversade, Institute of Medical Biology, A*STAR, SINGAPORE
Abstract title: Age-defying Proline, Because You Are Worth It
Yanhong Shi, Beckman Research Institute of City of Hope, USA
Abstract title: Modeling Neurological Diseases using Patient iPSCs
Toru Takumi, RIKEN Brain Science Institute, JAPAN
Abstract title: CNV Models for Autism Spectrum Disorders
Leslie Thompson, University of California Irvine, USA
Abstract title:Discovery and validation of therapeutic targets for Huntington's disease using HD iPS cells
Joseph Wu, Standford University, USA
Abstract title: Cardiac Stem Cells for Modeling Heart Disease and for Drug Discovery
Michael Yaffe, California Institute for Regenerative Medicine, USA
Abstract title:Large-scale Derivation and Banking of iPSCs for Complex Human Diseases
Su-chun Zhang, University of Wisconsin Madison, USA
Abstract title: Dissecting Early Pathogenesis in Neural Degeneration Using Human Stem Cells